# STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

> **NCT03347253** · — · TERMINATED · sponsor: **Amicus Therapeutics** · enrollment: 12 (actual)

## Conditions studied

- Late-onset Pompe Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03347253
- **Lead sponsor:** Amicus Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-08
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-11-30
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** As a result of change of clinical development plan.
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03347253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03347253, "STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03347253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*